换肤

艾迪药业

i问董秘

A03764

主营介绍

  • 主营业务：

    探索、研发和销售创新性化学药物以及人源蛋白产品

  • 产品类型：

    人源蛋白、药品、HIV诊断设备及试剂

  • 产品名称：

    乌司他丁粗品 、 尤瑞克林粗品 、 尿激酶粗品 、 乌司他丁中间体 、 药品 、 HIV诊断设备及试剂

  • 经营范围：

    药品研发、药品生产和销售；人尿蛋白、动物脏器和植物原料有效成分的开发、收购、加工与销售；技术研究开发与转让、技术咨询和技术服务；自营和代理一般商品及技术的进出口业务（不涉及国营贸易管理商品，涉及配额、许可证管理商品的按国家有关规定办理申请）。（经营范围不含国家实施外商投资准入特别管理措施的项目，依法须经批准的项目，经相关部门批准后方可开展经营活动）

主营构成分析

报告期
报告期
{"2019-12-31":{"YYSR":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","25957.40"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","5245.35"],["\u836f\u54c1","3265.91"]],"3":[["\u534e\u5357","22587.59"],["\u534e\u4e1c","6192.84"],["\u534e\u5317","1921.93"],["\u534e\u4e2d","1734.44"],["\u897f\u5317","1284.12"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",747.74]]},"YYCB":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","14514.04"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","3216.12"],["\u836f\u54c1","1974.32"]],"3":[["\u534e\u5357","11403.16"],["\u534e\u4e1c","4908.44"],["\u534e\u5317","1225.45"],["\u534e\u4e2d","995.02"],["\u897f\u5317","629.55"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",542.86]]},"LRBL":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","77.51"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","13.74"],["\u836f\u54c1","8.75"]],"3":[["\u534e\u5357","75.75"],["\u534e\u4e1c","8.70"],["\u534e\u5317","4.72"],["\u534e\u4e2d","5.01"],["\u897f\u5317","4.43"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",1.38]]}},"2019-06-30":{"YYSR":{"2":[["\u4eba\u6e90\u86cb\u767d","12433.27"],["\u836f\u54c1","1923.12"],["HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","1915.65"]],"3":[["\u897f\u5317","9979.82"],["\u534e\u5357","3658.97"],["\u534e\u4e2d","863.09"],["\u897f\u5357","655.90"],["\u534e\u4e1c","651.30"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",458.94]]},"YYCB":{"2":[["\u4eba\u6e90\u86cb\u767d","7419.51"],["\u836f\u54c1","1157.64"],["HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","114.88"]],"3":[["\u897f\u5317","5224.92"],["\u534e\u5357","2936.05"],["\u534e\u4e2d","522.07"],["\u897f\u5357","315.96"],["\u534e\u4e1c","401.00"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",320.03]]},"LRBL":{"2":[["\u4eba\u6e90\u86cb\u767d","66.14"],["\u836f\u54c1","10.10"],["HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","23.76"]],"3":[["\u897f\u5317","72.62"],["\u534e\u5357","11.04"],["\u534e\u4e2d","5.21"],["\u897f\u5357","5.19"],["\u534e\u4e1c","3.82"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",2.12]]}},"2018-12-31":{"YYSR":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","21779.56"],["\u836f\u54c1","2990.58"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","2916.95"]],"3":[["\u534e\u5357","19406.77"],["\u534e\u4e1c","4996.68"],["\u534e\u4e2d","1363.86"],["\u534e\u5317","1074.03"],["\u897f\u5317","462.69"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",383.06]]},"YYCB":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","11944.85"],["\u836f\u54c1","2331.80"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","2350.46"]],"3":[["\u534e\u5357","9843.21"],["\u534e\u4e1c","4201.14"],["\u534e\u4e2d","802.47"],["\u534e\u5317","776.28"],["\u897f\u5317","575.40"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",428.62]]},"LRBL":{"2":[["\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","88.92"],["\u836f\u54c1","5.96"],["\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","5.12"]],"3":[["\u534e\u5357","86.47"],["\u534e\u4e1c","7.19"],["\u534e\u4e2d","5.08"],["\u534e\u5317","2.69"],["\u897f\u5317","-1.02"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",-0.4102]]}}}
{"YYSR":{"chartWrap2":[{"name":"\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","timeData":["2019-12-31","2018-12-31"],"lineData":[25957.4,21779.56],"columnData":[75.31,78.66],"unit":["2.60\u4ebf","2.18\u4ebf"]},{"name":"\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-12-31","2018-12-31"],"lineData":[5245.35,2916.95],"columnData":[15.22,10.54],"unit":["5245.35\u4e07","2916.95\u4e07"]},{"name":"\u836f\u54c1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[3265.91,1923.12,2990.58],"columnData":[9.48,11.82,10.8],"unit":["3265.91\u4e07","1923.12\u4e07","2990.58\u4e07"]},{"name":"\u4eba\u6e90\u86cb\u767d","timeData":["2019-06-30"],"lineData":[12433.27],"columnData":[76.41],"unit":["1.24\u4ebf"]},{"name":"HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-06-30"],"lineData":[1915.65],"columnData":[11.77],"unit":["1915.65\u4e07"]}],"chartWrap3":[{"name":"\u534e\u5357","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[22587.59,3658.97,19406.77],"columnData":[65.53,22.49,70.09],"unit":["2.26\u4ebf","3658.97\u4e07","1.94\u4ebf"]},{"name":"\u534e\u4e1c","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[6192.84,651.3,4996.68],"columnData":[17.97,4,18.05],"unit":["6192.84\u4e07","651.30\u4e07","4996.68\u4e07"]},{"name":"\u534e\u5317","timeData":["2019-12-31","2018-12-31"],"lineData":[1921.93,1074.03],"columnData":[5.58,3.88],"unit":["1921.93\u4e07","1074.03\u4e07"]},{"name":"\u534e\u4e2d","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[1734.44,863.09,1363.86],"columnData":[5.03,5.31,4.93],"unit":["1734.44\u4e07","863.09\u4e07","1363.86\u4e07"]},{"name":"\u897f\u5317","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[1284.12,9979.82,462.69],"columnData":[3.73,61.35,1.67],"unit":["1284.12\u4e07","9979.82\u4e07","462.69\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[747.74,458.94,383.06],"columnData":[2.17,2.82,1.38],"unit":["747.74\u4e07","458.94\u4e07","383.06\u4e07"]},{"name":"\u897f\u5357","timeData":["2019-06-30"],"lineData":[655.9],"columnData":[4.03],"unit":["655.90\u4e07"]}]},"YYCB":{"chartWrap2":[{"name":"\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","timeData":["2019-12-31","2018-12-31"],"lineData":[14514.04,11944.85],"columnData":[73.66,71.84],"unit":["1.45\u4ebf","1.19\u4ebf"]},{"name":"\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-12-31","2018-12-31"],"lineData":[3216.12,2350.46],"columnData":[16.32,14.14],"unit":["3216.12\u4e07","2350.46\u4e07"]},{"name":"\u836f\u54c1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[1974.32,1157.64,2331.8],"columnData":[10.02,13.32,14.02],"unit":["1974.32\u4e07","1157.64\u4e07","2331.80\u4e07"]},{"name":"\u4eba\u6e90\u86cb\u767d","timeData":["2019-06-30"],"lineData":[7419.51],"columnData":[85.36],"unit":["7419.51\u4e07"]},{"name":"HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-06-30"],"lineData":[114.88],"columnData":[1.32],"unit":["114.88\u4e07"]}],"chartWrap3":[{"name":"\u534e\u5357","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[11403.16,2936.05,9843.21],"columnData":[57.87,30.21,59.2],"unit":["1.14\u4ebf","2936.05\u4e07","9843.21\u4e07"]},{"name":"\u534e\u4e1c","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[4908.44,401,4201.14],"columnData":[24.91,4.13,25.27],"unit":["4908.44\u4e07","401.00\u4e07","4201.14\u4e07"]},{"name":"\u534e\u5317","timeData":["2019-12-31","2018-12-31"],"lineData":[1225.45,776.28],"columnData":[6.22,4.67],"unit":["1225.45\u4e07","776.28\u4e07"]},{"name":"\u534e\u4e2d","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[995.02,522.07,802.47],"columnData":[5.05,5.37,4.83],"unit":["995.02\u4e07","522.07\u4e07","802.47\u4e07"]},{"name":"\u897f\u5317","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[629.55,5224.92,575.4],"columnData":[3.19,53.75,3.46],"unit":["629.55\u4e07","5224.92\u4e07","575.40\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[542.86,320.03,428.62],"columnData":[2.76,3.3,2.57],"unit":["542.86\u4e07","320.03\u4e07","428.62\u4e07"]},{"name":"\u897f\u5357","timeData":["2019-06-30"],"lineData":[315.96],"columnData":[3.25],"unit":["315.96\u4e07"]}]},"LRBL":{"chartWrap2":[{"name":"\u4eba\u6e90\u86cb\u767d\u7c97\u54c1","timeData":["2019-12-31","2018-12-31"],"lineData":[77.51,88.92],"columnData":[77.51,88.92],"unit":["77.51\u4e07","88.92\u4e07"]},{"name":"\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-12-31","2018-12-31"],"lineData":[13.74,5.12],"columnData":[13.74,5.12],"unit":["13.74\u4e07","5.12\u4e07"]},{"name":"\u836f\u54c1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[8.75,10.1,5.96],"columnData":[8.75,10.1,5.96],"unit":["8.75\u4e07","10.10\u4e07","5.96\u4e07"]},{"name":"\u4eba\u6e90\u86cb\u767d","timeData":["2019-06-30"],"lineData":[66.14],"columnData":[66.14],"unit":["66.14\u4e07"]},{"name":"HIV\u8bca\u65ad\u8bbe\u5907\u53ca\u8bd5\u5242","timeData":["2019-06-30"],"lineData":[23.76],"columnData":[23.76],"unit":["23.76\u4e07"]}],"chartWrap3":[{"name":"\u534e\u5357","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[75.75,11.04,86.47],"columnData":[75.75,11.04,86.47],"unit":["75.75\u4e07","11.04\u4e07","86.47\u4e07"]},{"name":"\u534e\u4e1c","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[8.7,3.82,7.19],"columnData":[8.7,3.82,7.19],"unit":["8.70\u4e07","3.82\u4e07","7.19\u4e07"]},{"name":"\u534e\u5317","timeData":["2019-12-31","2018-12-31"],"lineData":[4.72,2.69],"columnData":[4.72,2.69],"unit":["4.72\u4e07","2.69\u4e07"]},{"name":"\u534e\u4e2d","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[5.01,5.21,5.08],"columnData":[5.01,5.21,5.08],"unit":["5.01\u4e07","5.21\u4e07","5.08\u4e07"]},{"name":"\u897f\u5317","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[4.43,72.62,-1.02],"columnData":[4.43,72.62,-1.02],"unit":["4.43\u4e07","72.62\u4e07","-1.02\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2019-12-31","2019-06-30","2018-12-31"],"lineData":[1.38,2.12,-0.41],"columnData":[1.38,2.12,-0.41],"unit":["1.38\u4e07","2.12\u4e07","-4102"]},{"name":"\u897f\u5357","timeData":["2019-06-30"],"lineData":[5.19],"columnData":[5.19],"unit":["5.19\u4e07"]}]}}

营业收入 X

单位（%） 单位（万元）
注：通常在中报、年报时披露　
业务名称 营业收入(元) 收入比例 营业成本(元) 成本比例 利润比例 毛利率
按产品 人源蛋白粗品 2.60亿 75.31% 1.45亿 73.66% 77.51% 44.09%
诊断设备及试剂 5245.35万 15.22% 3216.12万 16.32% 13.74% 38.69%
药品 3265.91万 9.48% 1974.32万 10.02% 8.75% 39.55%
按地区 华南 2.26亿 65.53% 1.14亿 57.87% 75.75% 49.52%
华东 6192.84万 17.97% 4908.44万 24.91% 8.70% 20.74%
华北 1921.93万 5.58% 1225.45万 6.22% 4.72% 36.24%
华中 1734.44万 5.03% 995.02万 5.05% 5.01% 42.63%
西北 1284.12万 3.73% 629.55万 3.19% 4.43% 50.97%
西南 307.04万 0.89% 170.70万 0.87% 0.92% 44.41%
东北 270.69万 0.79% 199.56万 1.01% 0.48% 26.28%
其他 170.01万 0.49% 172.60万 0.88% -0.02% -1.52%

董事会经营评述

　　（一）营业收入分析
　　1、营业收入整体情况
　　2016年度、2017年度、2018年度和2019年1-6月，公司营业收入分别为25,784.23万元、13,626.44万元、27,690.56万元和16,280.88万元。报告期各期，公司主营业务收入占营业收入的比例均超过98%，主营业务突出。
　　2、主营业务收入构成
　　（1）人源蛋白销售
　　公司人源蛋白产品目前主要销售给天普生化。天普生化系国内独家拥有注射用乌司他丁、注射用尤瑞克林等人源蛋白注射剂品种的国有大型生物医药制造企业（2018年前为外资控股），公司作为国内领先的能够大规模向下游乌司他丁、尤瑞克林制剂厂商供应粗品的生产基... 查看全部▼

　　（一）营业收入分析
　　1、营业收入整体情况
　　2016年度、2017年度、2018年度和2019年1-6月，公司营业收入分别为25,784.23万元、13,626.44万元、27,690.56万元和16,280.88万元。报告期各期，公司主营业务收入占营业收入的比例均超过98%，主营业务突出。
　　2、主营业务收入构成
　　（1）人源蛋白销售
　　公司人源蛋白产品目前主要销售给天普生化。天普生化系国内独家拥有注射用乌司他丁、注射用尤瑞克林等人源蛋白注射剂品种的国有大型生物医药制造企业（2018年前为外资控股），公司作为国内领先的能够大规模向下游乌司他丁、尤瑞克林制剂厂商供应粗品的生产基地，双方形成了较为稳固的上下游战略合作关系。
　　2016年度、2017年度、2018年度及2019年1-6月，公司人源蛋白销售收入分别为23,980.45万元、11,211.02万元、21,779.56万元和12,433.27万元，2017年较2016年下降53.25%，2018年较2017年增长94.27%。公司2017年度人源蛋白产品收入出现大幅波动，主要原因为公司人源蛋白产品主要客户天普生化在正常情况下保有1-2个季度的备货库存，但2017年开始其当时的外资控股股东筹划转让股权，遂调整了内部存货管理，天普生化以消耗正常库存备货为主，导致公司乌司他丁粗品、尤瑞克林粗品等销售有所减少；2018年天普生化开始恢复正常，发行人对其销售亦相应恢复。
　　在2017年天普生化因内部原因减少采购备货情形下，公司转而向其他客户拓展尿激酶粗品销售市场，当年尿激酶粗品销售较2016年有较大幅度增长。自2018年以来，尿激酶粗品价格呈上涨趋势，2018年平均销售单价为7,726.94元/亿U，2019年1-6月平均销售单价为12,526.37元/亿U，较2018年全年平均价格上涨62.11%，主要是因为尿激酶粗品只能由传统工艺制得，随着环保卫生要求的提高，传统工艺愈发受限，尿激酶粗品市场供需逐步失衡所致。
　　（2）药品销售
　　2016年度、2017年度、2018年度及2019年1-6月，公司药品销售收入分别为1,502.80万元、2,243.57万元、2,990.58万元和1,923.12万元，2017年度较2016年度增长49.29%，2018年度较2017年度增长33.30%。
　　公司药品销售收入正处于快速增长阶段，主要产品为蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等，其中蜡样芽孢杆菌片和番泻叶颗粒为公司特色品种，未来拟进一步加大市场推广力度。2016年，公司药品销售业务处于收购的整合期以及业务的起步阶段，销量相对较小，2017年起，药品销售收入逐步稳定增长。
　　（3）HIV诊断设备及试剂销售
　　公司自2017年底开始经销美国雅培公司HIV诊断设备及试剂产品，为公司未来抗艾滋病创新药物上市前瞻布局销售渠道。报告期内，公司主要以直销方式面向医院、省市疾控中心开展业务。
　　报告期内，公司HIV诊断试剂主要品种为RealTime HIV-1病毒载量检测试剂。2017年度、2018年度和2019年1-6月，该试剂产品销售收入分别为66.85万元、2,117.81万元和1,769.75万元。由于发行人自2017年底开始开展该项业务，当年销售收入较低；2018年度，公司在北京、上海、河南、湖南、山西等7个省市中标，相关业务发展较好，但由于在河南、山西等省份的中标价格较低，导致2018年度销售单价较2017年度有所降低；2019年1-6月，公司在北京、湖南和新疆等高销售单价省市销售占比增加，导致当期平均单价上升。
　　3、主营业务收入按区域构成分析
　　公司的销售收入以华南、华东市场为主，系人源蛋白客户较为集中所致，第一大客户天普生化位于华南，第二大客户江苏尤里卡生物科技有限公司位于华东。
　　除华南、华东市场外，其他市场主要为公司药品销售以及HIV诊断设备及试剂销售业务相关，各期占比相对较小。 收起▲

同花顺个股页面 | F10论坛 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。